pharma-company /Medicinal products /Active ingredients

Rx · PZN 10764738

JURNISTA 64 mg prolonged-release tablets

German trade nameJURNISTA 64 mg Retardtabletten

Active ingredientHydromorphoneSubstance (DE)HydromorphonPharmaceutical formProlonged-release tablets

According to the data available to us: no longer marketed

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Ambient max. 25 °C

Highest known
purchase price (B2B)

~ €594

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for JURNISTA 64 mg prolonged-release tablets.

Review purchasing terms

JURNISTA 64 mg prolonged-release tablets contains the active ingredient Hydromorphone (German Hydromorphon) and comes as Prolonged-release tablets. One pack size is recorded (PZN 10764738). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.


According to the data available to us, JURNISTA 64 mg prolonged-release tablets is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.